Treatment of anaplastic glioma

Anaplastic gliomas have received increasing attention over the past years. As opposed to glioblastoma, where the focus has been on the evaluation of novel compounds (with mainly disappointing results), in anaplastic gliomas relevant progress was generated with genotoxic therapies and translational w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wick, Wolfgang (VerfasserIn) , Wiestler, Benedikt (VerfasserIn) , Platten, Michael (VerfasserIn)
Dokumenttyp: Kapitel/Artikel
Sprache:Englisch
Veröffentlicht: 2015
In: Current understanding and treatment of gliomas
Year: 2014, Pages: 89-101
DOI:10.1007/978-3-319-12048-5_6
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/978-3-319-12048-5_6
Volltext
Verfasserangaben:Wolfgang Wick, Benedikt Wiestler, Michael Platten

MARC

LEADER 00000caa a2200000 c 4500
001 1703725565
003 DE-627
005 20220818142119.0
007 cr uuu---uuuuu
008 200706r20152014xx |||||o 00| ||eng c
024 7 |a 10.1007/978-3-319-12048-5_6  |2 doi 
035 |a (DE-627)1703725565 
035 |a (DE-599)KXP1703725565 
035 |a (OCoLC)1341344680 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Wick, Wolfgang  |d 1970-  |e VerfasserIn  |0 (DE-588)120297736  |0 (DE-627)080586929  |0 (DE-576)186221320  |4 aut 
245 1 0 |a Treatment of anaplastic glioma  |c Wolfgang Wick, Benedikt Wiestler, Michael Platten 
264 1 |c 2015 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a First online: 03 December 2014 
500 |a Gesehen am 06.07.2020 
520 |a Anaplastic gliomas have received increasing attention over the past years. As opposed to glioblastoma, where the focus has been on the evaluation of novel compounds (with mainly disappointing results), in anaplastic gliomas relevant progress was generated with genotoxic therapies and translational work on biomarkers. Anaplastic gliomas are classified using single biomarkers, namely isocitrate dehydrogenase (IDH) or the related CpG island methylator phenotype (CIMP), alpha-thalassemia/mental retardation syndrome X-linked (ATRX), telomerase reverse transcriptase (TERT), p53, 1p/19q, and O6-methylguanine DNA-methyltransferase (MGMT). With these molecular biomarkers, three main prognostically distinct groups have been defined: (i) CIMP-negative anaplastic gliomas, which have a similar prognosis as glioblastoma, (ii) CIMP-positive 1p/19q intact, and (iii) CIMP-positive 1p/19q codeleted gliomas. In the CIMP-negative, mainly IDH wild-type group, MGMT promoter methylation may be used to identify patients who benefit from alkylating chemotherapy. The mutually exclusive ATRX losses and 1p/19q codeletions are used to subcategorize anaplastic tumors with a mixed histology according to microscopic features. This eliminates the biological basis and clinical necessity for the diagnosis of mixed gliomas (anaplastic oligoastrocytomas). Retrospective long-term analysis of the EORTC 26951 and RTOG 9402 trials revealed that patients with tumors harboring 1p/19q codeletions benefit from addition of procarbazine, lomustine, and vincristine (PCV) chemotherapy to primary radiotherapy. RTOG 9402 suggests that this may be the case also for patients with 1p/19q intact tumors, but IDH mutation. Future developments in addition to the ongoing CATNON and CODEL trials, will focus on further refinement of the molecular predictors and development of treatments that not only increase survival but also maintain neurological function, cognition, and health-related quality of life. 
534 |c 2014 
650 4 |a 1p/19q codeletion 
650 4 |a 450k methylation arrays 
650 4 |a ATRX 
650 4 |a Brain tumor 
650 4 |a CATNON 
650 4 |a CCNU 
650 4 |a CODEL 
650 4 |a EORTC 
650 4 |a Glioma 
650 4 |a IDH 
650 4 |a MGMT 
650 4 |a NDRG1 
650 4 |a NOA 
650 4 |a Oligodendroglial tumor 
650 4 |a PCV 
650 4 |a Radiotherapy 
650 4 |a RTOG 
650 4 |a Steroid 
650 4 |a Temozolomide 
700 1 |a Wiestler, Benedikt  |d 1983-  |e VerfasserIn  |0 (DE-588)1014415837  |0 (DE-627)705225879  |0 (DE-576)348205139  |4 aut 
700 1 |a Platten, Michael  |d 1971-  |e VerfasserIn  |0 (DE-588)121627780  |0 (DE-627)081431848  |0 (DE-576)261969811  |4 aut 
773 0 8 |i Enthalten in  |t Current understanding and treatment of gliomas  |d Cham : Springer International Publishing, 2015  |g (2015), Seite 89-101  |h Online-Ressource (VI, 184 p. 9 illus., 8 illus. in color, online resource)  |w (DE-627)1654527114  |w (DE-576)424911086  |z 9783319120485  |7 nnam  |a Treatment of anaplastic glioma 
773 1 8 |g year:2015  |g pages:89-101  |g extent:13  |a Treatment of anaplastic glioma 
856 4 0 |u https://doi.org/10.1007/978-3-319-12048-5_6  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200706 
993 |a BookComponentPart 
994 |a 2015 
998 |g 121627780  |a Platten, Michael  |m 121627780:Platten, Michael  |d 910000  |d 911100  |e 910000PP121627780  |e 911100PP121627780  |k 0/910000/  |k 1/910000/911100/  |p 3  |y j 
998 |g 1014415837  |a Wiestler, Benedikt  |m 1014415837:Wiestler, Benedikt  |p 2 
998 |g 120297736  |a Wick, Wolfgang  |m 120297736:Wick, Wolfgang  |d 910000  |d 911100  |e 910000PW120297736  |e 911100PW120297736  |k 0/910000/  |k 1/910000/911100/  |p 1  |x j 
999 |a KXP-PPN1703725565  |e 3695740167 
BIB |a Y 
JSO |a {"physDesc":[{"extent":"13 S."}],"title":[{"title":"Treatment of anaplastic glioma","title_sort":"Treatment of anaplastic glioma"}],"relHost":[{"relMultPart":[{"dispAlt":"Cancer treatment and research","pubHistory":["Nachgewiesen 96.1998 -"],"note":["Gesehen am 30.10.13"],"language":["eng"],"disp":"Cancer Treatment and Research","origin":[{"publisher":"Springer ; Springer ; Kluwer","dateIssuedDisp":"1998-","publisherPlace":"New York, NY ; [Berlin ; Heidelberg] ; Boston, Mass. ; Dordrecht ; London","dateIssuedKey":"1998"}],"id":{"eki":["54600704X"],"zdb":["2389301-1"],"issn":["2509-8497"]},"recId":"54600704X","type":{"bibl":"serial","media":"Online-Ressource"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Cancer treatment and research","title":"Cancer treatment and research"}],"part":{"number":["163"],"number_sort":["163"]}}],"person":[{"given":"Jeffrey J.","display":"Raizer, Jeffrey J.","family":"Raizer","role":"edt"},{"given":"Andrew","display":"Parsa, Andrew","role":"edt","family":"Parsa"}],"language":["eng"],"note":["Includes bibliographical references"],"origin":[{"publisher":"Springer International Publishing ; Imprint: Springer","dateIssuedDisp":"2015","publisherPlace":"Cham ; s.l.","dateIssuedKey":"2015"}],"name":{"displayForm":["edited by Jeffrey Raizer, Andrew Parsa"]},"disp":"Treatment of anaplastic gliomaCurrent understanding and treatment of gliomas","type":{"bibl":"edited-book","media":"Online-Ressource"},"recId":"1654527114","id":{"doi":["10.1007/978-3-319-12048-5"],"eki":["1654527114"],"isbn":["9783319120485"]},"title":[{"title_sort":"Current understanding and treatment of gliomas","title":"Current understanding and treatment of gliomas"}],"physDesc":[{"extent":"Online-Ressource (VI, 184 p. 9 illus., 8 illus. in color, online resource)"}],"part":{"extent":"13","text":"(2015), Seite 89-101","year":"2015","pages":"89-101"}}],"person":[{"given":"Wolfgang","display":"Wick, Wolfgang","role":"aut","family":"Wick"},{"given":"Benedikt","role":"aut","family":"Wiestler","display":"Wiestler, Benedikt"},{"family":"Platten","role":"aut","display":"Platten, Michael","given":"Michael"}],"note":["First online: 03 December 2014","Gesehen am 06.07.2020"],"language":["eng"],"name":{"displayForm":["Wolfgang Wick, Benedikt Wiestler, Michael Platten"]},"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"2015"}],"id":{"doi":["10.1007/978-3-319-12048-5_6"],"eki":["1703725565"]},"recId":"1703725565","type":{"media":"Online-Ressource","bibl":"chapter"}} 
SRT |a WICKWOLFGATREATMENTO2015